RAND - INNOVATION IN MEDICAL TECHNOLOGY


Located in the internationally well-known Mirandola Bio-medical district, RanD is a knowledge-based company, established in 1999 exploiting more than 30 years’ experience in the bio-medical field.

The name RanD originates from the phonetic transcription of the English acronym R&D (Research and Development) direct expression of RanD core activity: the development of technologically innovative systems based on extracorporeal circulation technologies, marked, at the same time, by extremely simplified operative management.

Over the years RanD developed a whole range of products mainly focused on surgical oncology, but it also exploited its own know-how in the development of third-party cutting-edge projects in the fields of liver support, cardiopulmonary support and dialysis.

RanD directly handles the whole manufacturing cycles of equipment and disposable devices, thus ensuring highest quality standards for each manufacturing phase.

RanD products are currently distributed worldwide directly or through a capillary and steadily expanding distribution network, regularly retrained by RanD. Thanks to this well-established network, the customer can be provided with a highly professional and prompt after sales service.

During the years RanD has established a close collaboration with internationally renowned physicians, which provide an essential contribution to the development of systems that meet users’ needs. To this purpose RanD is in active cooperation with the organization committees of congresses and International scientific events; it also performs a constant training activity addressed to physicians and technicians in the field.

Mission

Serving patients with high technology products to achieve significant improvement for their health.

Milestones

Rand Biotech Mirandola Modena

1999

RanD establishment
Performer LRT. The first multifunctional system for extracorporeal circulation therapies: CRRT, Plasma Exchange, Artificial and Bio-Artificial Liver support, Surgical oncology.

2001

Performer LRTThe first multifunctional system for extracorporeal circulation therapies: CRRT, Plasma Exchange, Artificial and Bio-Artificial Liver support, Surgical oncology.
Performer CPB. The first high-rise heart-lung machine. One third footprint of legacy systems. Developed for Medtronic Inc.

2005

Performer CPBThe first high-rise heart-lung machine.One third footprint of legacy systems.Developed for Medtronic Inc.
Performer HT. The most advanced system for Hyperthermic perfusion in the field of surgical oncology

2008

RanD USA. FDA clearance of Performer HT & establishment of RanD USA in Miami (FL)

2012

RanD USAFDA clearance of Performer HT & establishment of RanD USA in Miami (FL)
Rigenerand. Spin-off company in the field of regenerative medicine

2016

RigenerandSpin-off company in the field of regenerative medicine